D.A. Davidson & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $391K | Buy |
7,119
+331
| +5% | +$18.2K | ﹤0.01% | 1144 |
|
|
2025
Q1 | $480K | Sell |
6,788
-746
| -10% | -$52.7K | ﹤0.01% | 1040 |
|
|
2024
Q4 | $495K | Buy |
+7,534
| New | +$495K | ﹤0.01% | 1020 |
|
|
2020
Q3 | – | Sell |
-5,284
| Closed | -$652K | – | 956 |
|
|
2020
Q2 | $652K | Sell |
5,284
-85
| -2% | -$10.5K | 0.01% | 532 |
|
|
2020
Q1 | $454K | Buy |
5,369
+233
| +5% | +$19.7K | 0.01% | 616 |
|
|
2019
Q4 | $434K | Buy |
5,136
+1,977
| +63% | +$167K | 0.01% | 716 |
|
|
2019
Q3 | $213K | Buy |
+3,159
| New | +$213K | ﹤0.01% | 900 |
|
|
2017
Q3 | – | Sell |
-250
| Closed | -$22K | – | 1186 |
|
|
2017
Q2 | $22K | Sell |
250
-200
| -44% | -$17.6K | ﹤0.01% | 1790 |
|
|
2017
Q1 | $39K | Buy |
450
+65
| +17% | +$5.63K | ﹤0.01% | 1607 |
|
|
2016
Q4 | $31K | Buy |
385
+250
| +185% | +$20.1K | ﹤0.01% | 1775 |
|
|
2016
Q3 | $12K | Buy |
135
+35
| +35% | +$3.11K | ﹤0.01% | 1992 |
|
|
2016
Q2 | $7K | Hold |
100
| – | – | ﹤0.01% | 2039 |
|
|
2016
Q1 | $8K | Sell |
100
-454
| -82% | -$36.3K | ﹤0.01% | 1947 |
|
|
2015
Q4 | $58K | Hold |
554
| – | – | ﹤0.01% | 1342 |
|
|
2015
Q3 | $58K | Sell |
554
-46
| -8% | -$4.82K | ﹤0.01% | 1301 |
|
|
2015
Q2 | $82K | Hold |
600
| – | – | ﹤0.01% | 1225 |
|
|
2015
Q1 | $74K | Buy |
+600
| New | +$74K | ﹤0.01% | 1263 |
|